OSRH
OSR HoldingsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About OSRH
Osr Holdings, Inc.
A global healthcare company
Healthcare Providers and Services
02/25/2020
03/17/2023
NASDAQ Stock Exchange
19
12-31
Common stock
10900 NE 4th Street, Suite 2300, Bellevue, WA 98004
--
OSR Holdings, Inc., was incorporated in Delaware on February 25, 2020. The company is a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. OSR aims to build and develop a powerful portfolio of innovative and potentially transformative therapies and healthcare solutions. Its current operating businesses (through three wholly-owned subsidiaries) include (i) the development of oral immunotherapies for the treatment of cancer, (ii) the development of design-enhanced biologics for age-related and other degenerative diseases, and (iii) the distribution of neurovascular interventional medical devices and systems in Korea. Business combination.
Company Financials
EPS
OSRH has released its 2025 Q3 earnings. EPS was reported at -0.1, versus the expected -0.12, beating expectations. The chart below visualizes how OSRH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
OSRH has released its 2025 Q3 earnings report, with revenue of 627.75K, reflecting a YoY change of -23.72%, and net profit of -3.19M, showing a YoY change of 4.82%. The Sankey diagram below clearly presents OSRH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
